文献速递泌尿生殖技术与安全MRPETCT

晚期前列腺癌的影像诊断与随访:临床视角与技术现状

Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
PubMed 文献 · Radiology · 2019-06-25

本文综述晚期前列腺癌影像学进展,指出新型治疗改善了生存,个体化治疗需要更精准影像。全身MRI及使用新型放射性药物的PET/CT、PET/MRI等下一代影像在精确局部分期、早期转移检出、寡转移识别和疗效评估方面快速发展,同时面临应用挑战。

要点

  • 全身MRI和基于新型放射性药物的PET/CT、PET/MRI等下一代影像可支持晚期前列腺癌管理路径的优化。
  • 更精确的局部分期、更早的转移检出、寡转移病的准确识别和最佳疗效评估是影像快速发展的领域。
  • 下一代影像在兑现治疗突破的临床承诺方面兼具潜力和挑战。

核心结论

  • 多种有效新型治疗使晚期前列腺癌管理发生重大变化并改善了疾病生存,个体化治疗时代更精准的影像可能帮助医生提供更好的诊疗。

研究设计与样本

  • 本文为综述,原文未报告检索范围、纳入文献数量及证据分级方法。

临床应用与阅片要点

  • 更准确的局部分期、更早的转移灶检出、寡转移病的准确识别以及最佳疗效评估是现代影像快速演进和扩展的领域。
  • 下一代影像模式包括全身MRI,以及使用新型放射性药物的PET与CT联合、PET与MRI联合的分子影像,为影像支持和优化晚期前列腺癌患者的管理路径创造了新机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The management of advanced prostate cancer has changed substantially with the availability of multiple effective novel treatments, which has led to improved disease survival. In the era of personalized cancer treatments, more precise imaging may help physicians deliver better care. More accurate local staging and earlier detection of metastatic disease, accurate identification of oligometastatic disease, and optimal assessment of treatment response are areas where modern imaging is rapidly evolving and expanding. Next-generation imaging modalities, including whole-body MRI and molecular imaging with combined PET and CT and combined PET and MRI using novel radiopharmaceuticals, create new opportunities for imaging to support and refine management pathways in patients with advanced prostate cancer. This article demonstrates the potential and challenges of applying next-generation imaging to deliver the clinical promise of treatment breakthroughs.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Perez-Lopez R, Tunariu N, Padhani AR, et al. Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art. Radiology. 2019. PMID: 31237493. doi:10.1148/radiol.2019181931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。